Dr. Jeffrey R. Jay, M.D.

Great Point Partners Llc

Assets Managed

$435.118M

Holdings

Last Quarter

2026 - Q1

Filed Date

11d ago

Growth Rate

41.09%(2Q avg: 34.14%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Great Point Partners Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 42 positions.

Assets under management

The assets under management (AUM) of Great Point Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 435.118M in assets, with a quarterly growth rate of 41.09% and a 2-quarter average growth rate of 34.14%. The portfolio is managed by Dr. Jeffrey R. Jay, M.D., and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
APGE Apogee Therapeutics Inc Recent Activity	7.24%	$31.48M 374,000 shares@ $84.17 avg price
VOR Vor Biopharma Inc Recent Activity Increased 27.73%	7.18%	$31.22M 1.75M shares@ $17.84 avg price	Increased 27.73%
ZURA Zura Bio Ltd Recent Activity Increased 10.49%	5.77%	$25.085M 4.216M shares@ $5.96 avg price	Increased 10.49%
AMLX Amylyx Pharmaceuticals Inc Recent Activity	5.6%	$24.325M 1.75M shares@ $13.9 avg price
IBRX Immunitybio Inc Recent Activity New Position	5.29%	$23.016M↓ Put 3.001M shares@ $7.67 avg price	New Position
NKTR Nektar Therapeutics Recent Activity Increased 50.17%	5.24%	$22.769M 316,453 shares@ $71.95 avg price	Increased 50.17%
SLGL Sol-gel Technologies Ltd Recent Activity New Position	5%	$21.735M 274,363 shares@ $79.23 avg price	New Position
ALMS Alumis Inc Recent Activity New Position	4.34%	$18.859M 856,061 shares@ $22.04 avg price	New Position
DRUG Bright Minds Biosciences Inc Recent Activity New Position	3.69%	$16.053M 220,000 shares@ $72.97 avg price	New Position
ANNX Annexon Inc Recent Activity New Position	3.19%	$13.85M 2.5M shares@ $5.54 avg price	New Position

1-10 of 42